Our COVID-19 Vaccine Study – What’s Next?

COVID-19 SCIENTIFIC RESOURCES

Our Science
COVID-19 SCIENTIFIC RESOURCES
COVID-19 SCIENTIFIC RESOURCES

COVID-19 SCIENTIFIC RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

COVID-19 CLINICAL TRIAL RESULTS

Our Science
Covid Update
Covid Updates

COVID-19 CLINICAL TRIAL RESULTS

Updates on our COVID-19 clinical trial.

VISIT OUR COVID-19 HUB

Your Health
GettyImages-1208505315_790x500.png
GettyImages-1208505315_1000x450_0.jpg

VISIT OUR COVID-19 HUB

Sharing resources to stay safe and updates on our efforts we hope could bring an end to the global health crisis.

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

THE ANTIGEN: #COVID19 PODCAST

Podcasts
the_antigen_image_380x700.png
the_antigen_image_1000x450.jpg

THE ANTIGEN: #COVID19 PODCAST

Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.

Cancer Screening: Get it Done

Your Health
cancer_screening_get_it_done_790x500.png
cancer_screening_get_it_done_1000x450.jpg

Cancer Screening: Get it Done

A new initiative encourages people to speak with their doctor about keeping up with cancer screenings & follow-up appointments, where it’s safe to do so, during the COVID-19 pandemic.

Latest News

U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174; Companies are ready to deliver the first doses to the U.K. immediately First authorization for a COVID-19 vaccine represents a breakthrough scientific achievement to help combat this devastating pandemic The companies previously signed an agreement to supply a total of 40 million doses to the U.K. with delivery in 2020 and 2021 U.S. FDA and EU EMA decisions on authorization are expected…